Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (131-140 of 240) with videos related to

Pageof 24
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursJ Bennouna, P Fumoleau, J-P Armand, et al.
La Nouvelle Presse Medicale|February 14, 1976
[The half-life of iodine 131-labelled fibrinogen in cancer patients. Effects of heparin]A Boneu, J P Armand, A Blasco, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
New approach to metabolism of 5'-deoxy-5-fluorouridine in humans with fluorine-19 NMRM C Malet-Martino, R Martino, A Lopez, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTCP Hurteloup, P Chollet, H Roche, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Phase II study of mitozolomide (M & B 39,565) in head and neck cancerP Herait, J P Armand, M Benahmed, et al.
Cancer|August 15, 1990
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancerE Tellez-Bernal, G Recondo, T Guillot, et al.
Bulletin Du Cancer|February 15, 2001
[Zd 1839 "Iressa"]J B Meric, S Faivre, C Monnerat, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1983
Detection of fluoropyrimidines and their metabolites in biological samples by fluorine-19 NMR: application to 5'-deoxy-5-fluorouridineM C Malet-Martino, R Martino, A Lopez, et al.
Cancer Research|April 1, 1986
Evidence for the importance of 5'-deoxy-5-fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometryM C Malet-Martino, J P Armand, A Lopez, et al.
Cancer Treatment Reports|March 1, 1981
Phase II clinical trial of VP-16-213 in ovarian cancerA P Maskens, J P Armand, A J Lacave, et al.
Pageof 24

Showing results (131-140 of 240) with videos related to

Sort By:
Pageof 24
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursJ Bennouna, P Fumoleau, J-P Armand, et al.
La Nouvelle Presse Medicale|February 14, 1976
[The half-life of iodine 131-labelled fibrinogen in cancer patients. Effects of heparin]A Boneu, J P Armand, A Blasco, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
New approach to metabolism of 5'-deoxy-5-fluorouridine in humans with fluorine-19 NMRM C Malet-Martino, R Martino, A Lopez, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTCP Hurteloup, P Chollet, H Roche, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Phase II study of mitozolomide (M & B 39,565) in head and neck cancerP Herait, J P Armand, M Benahmed, et al.
Cancer|August 15, 1990
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancerE Tellez-Bernal, G Recondo, T Guillot, et al.
Bulletin Du Cancer|February 15, 2001
[Zd 1839 "Iressa"]J B Meric, S Faivre, C Monnerat, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1983
Detection of fluoropyrimidines and their metabolites in biological samples by fluorine-19 NMR: application to 5'-deoxy-5-fluorouridineM C Malet-Martino, R Martino, A Lopez, et al.
Cancer Research|April 1, 1986
Evidence for the importance of 5'-deoxy-5-fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometryM C Malet-Martino, J P Armand, A Lopez, et al.
Cancer Treatment Reports|March 1, 1981
Phase II clinical trial of VP-16-213 in ovarian cancerA P Maskens, J P Armand, A J Lacave, et al.
Pageof 24